4-[(4-methylbenzyl)thio]pyridine | 100394-49-8

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-[(4-methylbenzyl)thio]pyridine
• 英文别名: 4-(4-methyl-benzylmercapto)-pyridine；4-(4-Methyl-benzylmercapto)-pyridin；4-(4-Methylbenzylthio)-pyridine；4-[(4-methylphenyl)methylsulfanyl]pyridine
• CAS: 100394-49-8
• 化学式: C₁₃H₁₃NS
• 分子量: 215.319
• InChiKey: RRSBOZISJGAASX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  38.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(ω-bromoheptoxy)estra-1,3,5(10)-trien-17-one 、 4-[(4-methylbenzyl)thio]pyridine 以 乙腈 为溶剂， 反应 26.0h， 以42%的产率得到4-(4-methylbenzylsulfanyl)-1-[7-(17-oxoestra-1,3,5⁽¹⁰⁾-trien-3-yloxy)heptyl]pyridinium bromide
  参考文献：
  名称：

  Hybrid molecules of estrone: New compounds with potential antibacterial, antifungal, and antiproliferative activities

  摘要：

  New hybrid molecules of estrone were synthesized as compounds indicating promising biological activity (antibacterial, antimycobacterial, antifungal, and antiproliferative). The prepared molecules contained various heterocyclic units (pyridine, benzylsulfanyl derivatives of pyridine or derivatives of tetrazole) linked to estrone by n-heptyl bridges. The compounds with charge on molecule (the hybrid pyridinium or benzylsulfanylpyridinium salts) exhibited significant biological activity (antibacterial, antimycobacterial, antifungal, and antiproliferative). On the other hand, the compounds not in the form of salts (omega-(1-phenyl-5-tetrazolylthio)heptylethers of estrone) were inactive. The antimycobacterial activities of three different series of tetrazole derivatives (i.e., the hybrid molecules with estrone, tetrazole-5-thiols, and 5-benzylsulfanyl-1-phenyltetrazoles) with the same substituents on phenyl ring were compared. Amongst them, the 5-benzylsulfanyl-1-phenyltetrazoles were the most potent. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.02.021
• 作为产物：
  描述：

  吡啶-4(1H)-硫酮 、 alkaline earth salt of/the/ methylsulfuric acid 在 乙醇 、 sodium ethanolate 作用下， 生成 4-[(4-methylbenzyl)thio]pyridine
  参考文献：
  名称：

  有机硫化物对温室红蜘蛛螨卵和幼虫的毒性。vii.-苄基苯基硫化物（α-取代）

  摘要：

  描述了许多苄基部分的 α 位取代的苄基苯基硫化物的合成，并列出了它们对温室红蜘蛛（Tetranychus telarius L.）的卵和幼螨的毒性。

  DOI：

  10.1002/jsfa.2740090305

文献信息

• INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
  申请人：Dumas Jacques

  公开号：US20120046290A1

  公开（公告）日：2012-02-23

  This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

  本发明涉及一组芳香脲在治疗细胞因子介导的疾病（除癌症外）和蛋白水解酶介导的疾病（除癌症外）中的用途，以及用于此类治疗的药物组合物。
• Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
  申请人：Miller Scott

  公开号：US20080269265A1

  公开（公告）日：2008-10-30

  This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

  这项发明涉及使用一组芳基脲类化合物治疗raf介导的疾病，以及用于该疗法的药物组合物。
• INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS
  申请人：Dumas Jacques

  公开号：US20070244120A1

  公开（公告）日：2007-10-18

  Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

  治疗由raf激酶介导的肿瘤的方法，包括使用取代脲化合物，以及这些化合物本身。
• Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas
  申请人：DUMAS Jacques

  公开号：US20120129893A1

  公开（公告）日：2012-05-24

  Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

  使用替代尿素化合物治疗由raf激酶介导的肿瘤的方法，以及这种化合物本身。
• Antimycobacterial Agents. 1. Thio Analogues of Purine
  作者：Ashish K. Pathak、Vibha Pathak、Lainne E. Seitz、William J. Suling、Robert C. Reynolds

  DOI：10.1021/jm030389b

  日期：2004.1.1

  Thio analogues of purine, pyridine, and pyrimidine were prepared based on the initial activity screening of several analogues of these heterocycles against Mycobacterium tuberculosis (Mtb). Certain 6-thio-substituted purine analogues described herein showed moderate to good inhibitory activity. In particular, two purine analogues 9-(ethylcarboxymethyl)-6-(decylthio)9H-purine (20) and 9-(ethylcarboxymethyl)-6-(dodecylthio)-9H-purine (21) exhibited MIC values of 1.56 and 0.78 mug/mL respectively against the Mtb H(37)Rv strain. N-9-Substitution apparently enhances the antimycobacterial activity in the purine series described herein.